As patients lose weight on GLP-1 therapy, increased mobility often becomes feasible, creating opportunities for enhanced physical activity that further supports weight management and joint function
The drugs side effects are expected to be similar when used off-label for weight loss
Research suggests that propionyl-L-carnitine may improve blood flow in people with lower extremity peripheral artery disease (PAD), which may help improve exercise performance
Our new analyses provide assurance that the medication, when taken by individuals who are free of significant mental health concerns, does not increase the risk of depression, suicidal thoughts, or suicidal behavior, said Professor Thomas A
Improvements in glycaemic control over a 12-month period are known to be associated with an improvement in both systolic (as measured through GLS) and diastolic parameters (expressed by mitral E/e ratio) in T2D subjects without overt cardiac disease, irrespective of the glucose-lowering agent used [76]
Rapid Weight Loss Thins the Skin's UV Cushion One of the most visible effects of GLP-1 agonists like Wegovy is significant weight loss